FDA 最高药品监管机构在联邦调查该机构的运作后辞职。 FDA's top drug regulator resigns after federal probe into agency's operations.

美国FDA的最高药品监管机构在联邦调查发现了有关该机构运作"严重担忧"后辞职, The U.S. FDA's top drug regulator has resigned following a federal investigation that uncovered "serious concerns" about the agency's operations, though specific details remain undisclosed. 调查侧重于监管廉正和决策,在公众对毒品安全和批准时限的严格审查期间,有助于领导层的转变。 The probe focused on regulatory integrity and decision-making, contributing to the leadership change during a period of heightened public scrutiny over drug safety and approval timelines. 美国食品药品管理局确认该人已不再担任职务, The FDA confirmed the individual is no longer in office and is appointing an interim leader while seeking a permanent replacement.